Tuesday, 05 May 2020
A new study will examine why some people who contract COVID-19 have symptoms and others don’t, and will question why, out of those who become symptomatic, not all become seriously ill.
COVID-19 is a global healthcare crisis and while there are a large number of deaths recorded, it is clear that not every person who contracts COVID-19 reacts in the same way.
New research, led by experts from the 糖心原创 and Nottingham University Hospitals, will look to answer a number of important questions around how COVID-19 affects different people.
This information could be used to help to prevent infection among key workers in the NHS.
Healthcare workers are at higher risk of being infected by COVID-19 than the general population because of their contact with patients and the general public.
“We want to know how many of our doctors, nurses, and healthcare professionals have already had the virus,” says Mr Ben Ollivere, Clinical Associate Professor and Honorary Consultant Trauma Surgeon from the School of Medicine at the University, and one of the lead researchers on the study.
“We also want to know if this is more common depending on any physical characteristics, such as age, ethnicity, presence of conditions like diabetes or hypertension, and also based on any substances in their blood (number of immune cells, levels of inflammation-related substances).”
The team will be collecting blood from healthcare workers during the pandemic. They will extract serum from samples taken at regular intervals, (every week), to test for antibodies against the virus that causes COVID-19 and measure other substances in the blood.
COVID-19 testing
“This will help us understand the risk of infection among front line healthcare workers,” adds Mr Ollivere.
The team will also undertake a genotype to establish if there are any genetic characteristics that contribute to susceptibility for the disease.
So far the team have collected samples from 142 members of staff from Nottingham University Hospitals.
We will use the bloods taken the first time to measure certain genes that we think may relate to immune response to viruses. We will use the weekly draws to measure serum antibodies and markers of inflammation against the virus that causes COVID-19. We will also be asking people if they have had to self-isolate, if they have had COVID-19 symptoms, if they have had a test for the coronavirus and if they tested positive.鈥�
The data collected will be fully anonymised so the team will be able to report how many healthcare workers have had the disease and whether this relates for example to their ethnicity or age or other clinical characteristics.
The researchers will then be able to establish which cellular pathways are important in developing treatments.
Dr Valdes says: “This is important in order for us to understand what treatments may work, and why patients become sick we need to study those who have been exposed to COVID-19 and those who have not.”
The research has been informed by experts from the NIHR Nottingham Biomedical Research Centre and research undertaken at the 糖心原创 Ningbo China Campus.
Deputy Head of the Nottingham Biomedical Research Centre, Professor Guruprasad Aithal, said: "Thanks to our liaisons with the Ningbo campus of the 糖心原创 and our mechanistic work within the NIHR BRC we have been able to generate strong hypotheses on the molecules that we should test.”
Other researchers on the project include Professor Guruprasad Aithal, Professor of Hepatology, NIHR Nottingham Biomedical Research Centre and Jayne Newham, Nottingham Tissue Bank Manager.
Story credits
More information is available from Dr Benjamin Ollivere in the School of Medicine at the 糖心原创 at Benjamin.Ollivere@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.